STI Stock Trade Intelligence
CSL

CSL Ltd

Health Care · ASX:CSL
$202.52
▼ -0.20%
Market cap
$97.19B
Turnover
$142,243,392
Last price
$202.52
Day change
-0.20%
Announcements
9
Range, past year
Open 180.4 · Low 90.00 · Now 202.5 · High 275.7
Open CSL in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.

CSL momentum and trend analysis

Our analysis
Independent analysis generated by Stock Trade Intelligence as at 2026-11-16.
Momentum quality
75/100
Wyckoff phase
Uptrend22d
Trend stage
Neutral
1 Day
-0.2%
1 Week
+0.9%
1 Month
+5.4%
1 Year
+11.4%
RSI
67
Avg daily range
1.8%

CSL Ltd scores 75 out of 100 for momentum quality, a reading rated high confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.

On the Wyckoff cycle it sits in Uptrend, where it has been for 22 trading days. The weekly timeframe reads Uptrend, which agrees with the daily view.

Against the wider market it is currently matching and the institutional accumulation signal reads high.

What stands out
  • Solid momentum quality (MQS 75)
  • Trend R² 0.90 — highly linear uptrend
  • Above SMA50 for 107 days
  • Within 1.4% of 52-week high
  • Institutional accumulation: High
  • RSI in healthy zone (67)
Points to watch
  • MACD histogram turning down
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highs

CSL announcements

Recent price-sensitive releases.
  • 2026-10-22 CSL to Defend Class Action Company Administration - Other
  • 2026-10-21 Appointment of New CEO CEO/Managing Director - Appointment Resignation
  • 2026-10-05 CSL enters exclusive agreement with Alentis Therapeutics Progress Report
  • 2026-08-18 CSL Results Presentation for FY2026 Company Presentation | Preliminary Final Report
  • 2026-08-18 CSL FY2026 Results Web Cast | Preliminary Final Report | Dividend Rate
  • 2026-08-18 CSL Statutory Accounts for FY2026 Sustainability/Climate Action Report | Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report | Notice of Meeting - Other | Dividend Record Date | Dividend Pay Date | Dividend Rate
  • 2026-07-29 CSL Update on Enhanced Plasma Manufacturing Progress Report
Get the daily briefing The day's price-sensitive announcements, ranked by what actually moved, with our own momentum and cycle read on each.